L. Carter Bruce - Aug 12, 2022 Form 4 Insider Report for Mirati Therapeutics, Inc. (MRTX)

Role
Director
Signature
/s/Reena Desai, Attorney-in-Fact
Stock symbol
MRTX
Transactions as of
Aug 12, 2022
Transactions value $
-$584,899
Form type
4
Date filed
8/16/2022, 04:15 PM
Previous filing
Mar 22, 2022
Next filing
Jan 24, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MRTX Common Stock Options Exercise $270K +10K +166.09% $27.00 16K Aug 12, 2022 Direct
transaction MRTX Common Stock Sale -$434K -5.11K -31.88% $85.04 10.9K Aug 12, 2022 Direct F1
transaction MRTX Common Stock Sale -$421K -4.89K -44.83% $85.96 6.02K Aug 12, 2022 Direct F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction MRTX Non Qualified Stock Option (right to buy) Options Exercise $0 -10K -100% $0.00* 0 Aug 12, 2022 Common Stock 10K $27.00 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This transaction was executed in multiple trades at prices ranging from $84.55 to $85.47. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F2 This transaction was executed in multiple trades at prices ranging from $85.60 to $86.555. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
F3 The shares subject to the Option vested and became exercisable in 12 equal monthly installments following the date of grant.